Meeting on the Mesa 2021 | Impact of COVID-19 on the advanced therapies sector

Christian Schneider, MD, Biopharma Excellence, Munich, Germany, discusses the effects of the COVID-19 pandemic on the advanced therapies sector. Development of cell and gene therapies were accelerated due to the pandemic, as there was an increased focus on solving unmet needs. Regulatory pathways were additionally optimized during COVID-19, enabling expedited authorization of various advanced therapies. This interview took place at Meeting on the Mesa 2021.

 

 

  Go Back

Start a conversation today

Socials: